Reply to "CRISPR screens are feasible in TP53 wild-type cells"
- PMID: 31464368
- PMCID: PMC6686827
- DOI: 10.15252/msb.20199059
Reply to "CRISPR screens are feasible in TP53 wild-type cells"
Abstract
Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups.
© 2019 The Authors. Published under the terms of the CC BY 4.0 license.
Comment on
-
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.Nat Med. 2018 Jul;24(7):927-930. doi: 10.1038/s41591-018-0049-z. Epub 2018 Jun 11. Nat Med. 2018. PMID: 29892067
-
CRISPR screens are feasible in TP53 wild-type cells.Mol Syst Biol. 2019 Aug;15(8):e8679. doi: 10.15252/msb.20188679. Mol Syst Biol. 2019. PMID: 31464370 Free PMC article.
References
-
- Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J (2018) CRISPR–Cas9 genome editing induces a p53‐mediated DNA damage response. Nat Med 24: 927–930 - PubMed
-
- Ihry RJ, Worringer KA, Salick MR, Frias E, Ho D, Theriault K, Kommineni S, Chen J, Sondey M, Ye C et al (2018) p53 inhibits CRISPR‐Cas9 engineering in human pluripotent stem cells. Nat Med 24: 939–946 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
